CTOs on the Move

NextGate

www.nextgate.com

 
NextGate`s mission is to address the fundamental challenge of data management in the healthcare industry: the uncertainties and missed opportunities caused by duplicate and disconnected records in a data population. While implementing interface engine technology for hospitals in the early 1990s, we noticed a troubling trend – as application systems became integrated and exchanged data with each other, problems caused by duplicate and incomplete patient records (previously confined to one system and its MPI) multiplied and contaminated the data quality of other systems. Because this technical issue could impact a patient`s health, we made it our goal to find a solution. The ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.nextgate.com
  • 3579 E. Foothill Blvd. Suite #587
    Pasadena, CA USA 91107
  • Phone: 626.376.4100

Executives

Name Title Contact Details
Greg Rumple
Chief Information Security Officer Profile

Similar Companies

Latino Health Institute

Latino Health Institute is a Brockton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Helicos BioSciences

Helicos BioSciences Corporation is developing instruments for ultra-high-throughput sequencing of DNA or RNA without amplification.

cvsspecialty

CVS Specialty is a specialty pharmacy that provides medication management and personalized support for patients with complex or chronic conditions. They offer services such as Rx management, onboarding support, and online order tracking. CVS Specialty ...

Waiting Room Solutions

Waiting Room Solutions is a Goshen, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dimension Therapeutics

Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.